Go Pro

MarketBeat Instant News Alerts

Cullen/Frost Bankers logo with Finance background

Cullen/Frost Bankers (NYSE:CFR) Price Target Raised to $175.00 at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods upped their price target on shares of Cullen/Frost Bankers from $165.00 to $175.00 and gave the company an "outperform" rating in a report on Friday.

NYSE:CFR
Read Cullen/Frost Bankers (NYSE:CFR) Price Target Raised to $175.00 at Keefe, Bruyette & Woods
Blackstone Mortgage Trust logo with Finance background

Keefe, Bruyette & Woods Reaffirms Market Perform Rating for Blackstone Mortgage Trust (NYSE:BXMT)

Keefe, Bruyette & Woods restated a "market perform" rating and set a $16.00 target price (down from $20.00) on shares of Blackstone Mortgage Trust in a research report on Friday.

NYSE:BXMT
Read Keefe, Bruyette & Woods Reaffirms Market Perform Rating for Blackstone Mortgage Trust (NYSE:BXMT)
Boston Scientific logo with Medical background

Boston Scientific's (BSX) Hold Rating Reaffirmed at Argus

Argus restated a "hold" rating on shares of Boston Scientific in a research report on Friday.

NYSE:BSX
Read Boston Scientific's (BSX) Hold Rating Reaffirmed at Argus
Axos Financial logo with Finance background

Axos Financial (NYSE:AX) Given New $110.00 Price Target at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods increased their price target on Axos Financial from $105.00 to $110.00 and gave the stock a "market perform" rating in a report on Friday.

NYSE:AX
Read Axos Financial (NYSE:AX) Given New $110.00 Price Target at Keefe, Bruyette & Woods
Axos Financial logo with Finance background

Axos Financial (NYSE:AX) Given New $128.00 Price Target at Needham & Company LLC

Needham & Company LLC raised their target price on shares of Axos Financial from $110.00 to $128.00 and gave the company a "buy" rating in a research note on Friday.

NYSE:AX
Read Axos Financial (NYSE:AX) Given New $128.00 Price Target at Needham & Company LLC
Arthur J. Gallagher & Co. logo with Finance background

Arthur J. Gallagher & Co. (NYSE:AJG) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says

Keefe, Bruyette & Woods lifted their price objective on Arthur J. Gallagher & Co. from $261.00 to $271.00 and gave the company a "market perform" rating in a research note on Friday.

NYSE:AJG
Read Arthur J. Gallagher & Co. (NYSE:AJG) Stock Price Expected to Rise, Keefe, Bruyette & Woods Analyst Says

Trending News

All MarketBeat Instant News Alerts

First Majestic Silver logo with Basic Materials background

HC Wainwright Forecasts Strong Price Appreciation for First Majestic Silver (NYSE:AG) Stock

NYSE:AG
Read HC Wainwright Forecasts Strong Price Appreciation for First Majestic Silver (NYSE:AG) Stock
Tempus AI logo with Medical background

Needham & Company LLC Reaffirms Buy Rating for Tempus AI (NASDAQ:TEM)

NASDAQ:TEM
Read Needham & Company LLC Reaffirms Buy Rating for Tempus AI (NASDAQ:TEM)
Silvaco Group logo with Computer and Technology background

Rosenblatt Securities Reiterates Buy Rating for Silvaco Group (NASDAQ:SVCO)

NASDAQ:SVCO
Read Rosenblatt Securities Reiterates Buy Rating for Silvaco Group (NASDAQ:SVCO)
Starbucks logo with Retail/Wholesale background

Starbucks (NASDAQ:SBUX) Given "Buy" Rating at BTIG Research

NASDAQ:SBUX
Read Starbucks (NASDAQ:SBUX) Given "Buy" Rating at BTIG Research
Rivian Automotive logo with Auto/Tires/Trucks background

Rivian Automotive's (RIVN) Buy Rating Reiterated at Needham & Company LLC

NASDAQ:RIVN
Read Rivian Automotive's (RIVN) Buy Rating Reiterated at Needham & Company LLC
Plexus logo with Computer and Technology background

Sidoti Upgrades Plexus (NASDAQ:PLXS) to Buy

NASDAQ:PLXS
Read Sidoti Upgrades Plexus (NASDAQ:PLXS) to Buy
Pagaya Technologies logo with Finance background

Canaccord Genuity Group Issues Positive Forecast for Pagaya Technologies (NASDAQ:PGY) Stock Price

NASDAQ:PGY
Read Canaccord Genuity Group Issues Positive Forecast for Pagaya Technologies (NASDAQ:PGY) Stock Price
Omnicell logo with Medical background

Omnicell (NASDAQ:OMCL) Given New $65.00 Price Target at KeyCorp

NASDAQ:OMCL
Read Omnicell (NASDAQ:OMCL) Given New $65.00 Price Target at KeyCorp
Neurocrine Biosciences logo with Medical background

Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $204.00

NASDAQ:NBIX
Read Neurocrine Biosciences (NASDAQ:NBIX) Price Target Raised to $204.00
Strategy logo with Computer and Technology background

Strategy's (MSTR) "Buy" Rating Reiterated at BTIG Research

NASDAQ:MSTR
Read Strategy's (MSTR) "Buy" Rating Reiterated at BTIG Research
Monolithic Power Systems logo with Computer and Technology background

Monolithic Power Systems (NASDAQ:MPWR) Given "Neutral" Rating at Rosenblatt Securities

NASDAQ:MPWR
Read Monolithic Power Systems (NASDAQ:MPWR) Given "Neutral" Rating at Rosenblatt Securities
Monolithic Power Systems logo with Computer and Technology background

KeyCorp Forecasts Strong Price Appreciation for Monolithic Power Systems (NASDAQ:MPWR) Stock

NASDAQ:MPWR
Read KeyCorp Forecasts Strong Price Appreciation for Monolithic Power Systems (NASDAQ:MPWR) Stock
Merit Medical Systems logo with Medical background

Merit Medical Systems (NASDAQ:MMSI) Price Target Raised to $101.00

NASDAQ:MMSI
Read Merit Medical Systems (NASDAQ:MMSI) Price Target Raised to $101.00
Merit Medical Systems logo with Medical background

BTIG Research Forecasts Strong Price Appreciation for Merit Medical Systems (NASDAQ:MMSI) Stock

NASDAQ:MMSI
Read BTIG Research Forecasts Strong Price Appreciation for Merit Medical Systems (NASDAQ:MMSI) Stock
Medline logo with Manufacturing background

Medline's (MDLN) Buy Rating Reiterated at BTIG Research

NASDAQ:MDLN
Read Medline's (MDLN) Buy Rating Reiterated at BTIG Research
LPL Financial logo with Finance background

Keefe, Bruyette & Woods Issues Positive Forecast for LPL Financial (NASDAQ:LPLA) Stock Price

NASDAQ:LPLA
Read Keefe, Bruyette & Woods Issues Positive Forecast for LPL Financial (NASDAQ:LPLA) Stock Price
Karyopharm Therapeutics logo with Medical background

Karyopharm Therapeutics (NASDAQ:KPTI) Receives Neutral Rating from HC Wainwright

NASDAQ:KPTI
Read Karyopharm Therapeutics (NASDAQ:KPTI) Receives Neutral Rating from HC Wainwright
Columbia Sportswear logo with Consumer Discretionary background

Columbia Sportswear (NASDAQ:COLM) Receives Buy Rating from BTIG Research

NASDAQ:COLM
Read Columbia Sportswear (NASDAQ:COLM) Receives Buy Rating from BTIG Research
Coinbase Global logo with Finance background

Canaccord Genuity Group Reiterates Buy Rating for Coinbase Global (NASDAQ:COIN)

NASDAQ:COIN
Read Canaccord Genuity Group Reiterates Buy Rating for Coinbase Global (NASDAQ:COIN)
Coinbase Global logo with Finance background

Needham & Company LLC Has Lowered Expectations for Coinbase Global (NASDAQ:COIN) Stock Price

NASDAQ:COIN
Read Needham & Company LLC Has Lowered Expectations for Coinbase Global (NASDAQ:COIN) Stock Price
Chime Financial logo with Financial Services background

Chime Financial's (CHYM) "Buy" Rating Reiterated at Canaccord Genuity Group

NASDAQ:CHYM
Read Chime Financial's (CHYM) "Buy" Rating Reiterated at Canaccord Genuity Group
Coastal Financial logo with Finance background

Keefe, Bruyette & Woods Lowers Coastal Financial (NASDAQ:CCB) Price Target to $53.00

NASDAQ:CCB
Read Keefe, Bruyette & Woods Lowers Coastal Financial (NASDAQ:CCB) Price Target to $53.00
Capricor Therapeutics logo with Medical background

JonesTrading Reaffirms Hold Rating for Capricor Therapeutics (NASDAQ:CAPR)

NASDAQ:CAPR
Read JonesTrading Reaffirms Hold Rating for Capricor Therapeutics (NASDAQ:CAPR)
First Busey logo with Finance background

First Busey (NASDAQ:BUSE) Price Target Raised to $34.00 at Keefe, Bruyette & Woods

NASDAQ:BUSE
Read First Busey (NASDAQ:BUSE) Price Target Raised to $34.00 at Keefe, Bruyette & Woods

Featured Articles and Offers

Alert Categories

All Alerts